Lacutamab Uses, Dosage, Side Effects and more
Lacutamab is under investigation in clinical trial NCT02593045 (Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)).
| Attribute | Details |
|---|---|
| Trade Name | Lacutamab |
| Generic | Lacutamab |
| Lacutamab Other Names | Lacutamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
